QXZS in Menopausal Syndrome Based on 16S rRNA Sequencing Technology

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

August 31, 2024

Study Completion Date

June 30, 2025

Conditions

Menopause

Interventions

DRUG

Qingxin Zishen decoction

Oral administration, 1 dose daily, twice a day

DRUG

Femoston

Oral administration, 1 pill each time, once a day

Trial Locations (1)

RECRUITING

Yuxin Zhou, Nanjing

All Listed Sponsors

lead

Yun Chen

OTHER